Charles McCluskey III, PharmD, MBA, CPEL (Charles.McCluskeyIII@ohiohealth.com), is the system vice-president, chief pharmacy officer at OhioHealth in Columbus, OH. He earned a B.S. in pharmacy from Ohio Northern University and his PharmD and MBA from The Ohio State University. He has served as a program director for PGY1 and PGY2 ASHP-accredited residency programs for 15+ years; presently serving as the executive sponsor for the organization’s PGY1/2 health-system pharmacy administration and leadership (HSPAL) programs. McCluskey has been active with ASHP at the state and national level. He has served as faculty for Conference for Pharmacy Leaders; facilitator for Midyear Clinical Meeting networking sessions; a member of the Section of Pharmacy Practice Leaders (SPPL) Multi-Hospital Pharmacy Executive Committee, and faculty for an SPPL Webinar. At the state level, he has been active within the Ohio Society of Health-System Pharmacists(OSHP) divisions of legal affairs and professional affairs, co-authoring multiple position statements. He serves as adjunct faculty at multiple schools of pharmacy with a focus on pharmacy leadership topics.
Meet Name
Medications are projected to have the largest growth among patient treatment modalities over the next decade. This uniquely positions health-system pharmacy to influence the future of care delivery by advancing value at scale. I believe our responsibility as leaders is to ensure pharmacy is fully integrated into the health-system strategy - driving measurable improvements in clinical outcomes while optimizing the total cost of care. This requires disciplined stewardship of medication resources, but more importantly, the ability to clearly demonstrate our impact through data, outcomes, and aligned system priorities - communicated via patient-centered, organizational aligned patient stories. Equally critical is the evolution of our practice models and workforce. The sustainability of our profession depends on our ability to redesign care delivery - empowering pharmacists and technicians to practice at the top of their training, while creating meaningful career pathways that support engagement, resilience, and long-term growth. Investing in our people is not optional; it is foundational to advancing practice and ensuring consistent, high-quality care. Finally, the continued expansion of ambulatory and specialty pharmacy services represents one of the most significant opportunities to extend our impact. By strengthening our presence across the continuum of care, we can improve access, enhance care coordination, and deliver more personalized, longitudinal medication management that improves outcomes and patient experience. It would be an honor to serve as director-at-large of the Section. I am committed to partnering with ASHP members to advance these priorities and to elevate pharmacy’s role as a strategic leader in transforming health care delivery.